New research supports Kemin’s nootropic ingredient may support neural tissues in the eye

Kemin Industries (Des Moines, IA) stated that a new study presented at the annual meeting of the Association for Visual and Ophthalmology annual meeting shows in April suggests that the company's Neumentix intelligence promoting ingredients may also support the neural tissue of the eyes.

Kemin's research partner is the University of Pisa in Italy. At the meeting, Dr. Rosario Amato, PhD, a postdoctoral researcher at the University of Pisa, introduced the data collected from this study in a rat model of hypertensive glaucoma.

“Our findings emphasized the intraocular pressure–independent antioxidant and neuroprotective effects of Neumentix,”Amato said during a press release.

Massimo Dal Monte, the study’s principal investigator and a professor at the University of Pisa also added:“The study findings validated Neumentix’s expanded mechanisms of action that are effective for neural tissues beyond the brain. Results indicated the Neumentix, Kemin’s natural spearmint (Mentha spicata L.) extract, sourced from patented plants and characterized by its phenolic complex, works to counteract common degenerative pathways in the eyes and brain.”